New posts

Reply to thread

Message

I wouldn't say as big as csl, but it certainly jumped out of the gate, On top of that announcement...

SYDNEY, Australia, 21 April 2021:Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, today announced a clinical milestone has been achieved for its HER-Vaxx cancerimmunotherapy in the Phase 2 gastric cancer clinical trial. Following completion of recruitment in January 2021, the important clinical endpoint of Progression Free Survival (PFS) has been met after the statistically significant required number of PFS events has occurred. Data from these 24 events will now be analysed with the final PFS read-out expected within months.

I look forward to watching it's progress climb in those next couple of months, and onward, with the progression of its achievements.

I'd like to refer back to Barneys post earlier;

A lot of potential here; https://www.imugene.com/

<blockquote data-quote="Stockbailx" data-source="post: 1121217" data-attributes="member: 85616">I wouldn&#039;t&nbsp; say as big as csl, but it certainly jumped out of the gate, On top of that announcement...SYDNEY,&nbsp; Australia, 21&nbsp; April 2021:Imugene&nbsp; Limited&nbsp; (ASX:IMU),&nbsp; a&nbsp; clinical&nbsp; stage&nbsp; immuno-oncology company,&nbsp; today&nbsp; announced a&nbsp; clinical&nbsp; milestone&nbsp; has&nbsp; been&nbsp; achieved&nbsp; for&nbsp; its&nbsp; HER-Vaxx&nbsp; cancerimmunotherapy in the Phase 2 gastric cancer clinical trial.&nbsp; Following&nbsp;&nbsp; completion&nbsp;&nbsp; of&nbsp;&nbsp; recruitment&nbsp;&nbsp; in&nbsp;&nbsp; January&nbsp;&nbsp; 2021,&nbsp;&nbsp; the&nbsp;&nbsp; important&nbsp;&nbsp; clinical&nbsp;&nbsp; endpoint&nbsp;&nbsp; of Progression Free Survival (PFS) has been met after the statistically significant required number of PFS events has occurred.&nbsp; Data from these 24 events will now be analysed with the final PFS read-out expected within months.&nbsp; I look forward to watching it&#039;s progress climb in those next couple of months, and onward, with the progression of its achievements.&nbsp;I&#039;d like to refer back to Barneys post earlier;A lot of potential&nbsp; here; <a href="https://www.imugene.com/" target="_blank">https://www.imugene.com/</a> <img src="https://www.aussiestockforums.com/styles/default/xenforo/smilies/twocents.gif"&nbsp; class="smilie" loading="lazy" alt=":2twocents" title="Two Cents&nbsp; &nbsp; :2twocents" data-shortname=":2twocents" /></blockquote>

[QUOTE="Stockbailx, post: 1121217, member: 85616"] I wouldn't say as big as csl, but it certainly jumped out of the gate, On top of that announcement... [I]SYDNEY, Australia, 21 April 2021:Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, today announced a clinical milestone has been achieved for its HER-Vaxx cancerimmunotherapy in the Phase 2 gastric cancer clinical trial. Following completion of recruitment in January 2021, the important clinical endpoint of Progression Free Survival (PFS) has been met after the statistically significant required number of PFS events has occurred. Data from these 24 events will now be analysed with the final PFS read-out expected within months. [/I] I look forward to watching it's progress climb in those next couple of months, and onward, with the progression of its achievements. I'd like to refer back to Barneys post earlier; A lot of potential here; [URL]https://www.imugene.com/[/URL] :2twocents [/QUOTE]

Verification